Marcelo F. Di Carli, MD, FACC

Quick facts

Phase 2 pipeline

• 18F-FET · Oncology
  18F-FET is a positron-emitting radiopharmaceutical used for imaging of gliomas and other brain tumors.

Phase 1 pipeline

• Indium-111 Pentreotide

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Marcelo F. Di Carli, MD, FACC portfolio CI brief
• Marcelo F. Di Carli, MD, FACC pipeline updates RSS

Related

• Sector hub: All tracked pharma companies